logo
EU shores up pandemic defences with 478m flu vaccine deal

EU shores up pandemic defences with 478m flu vaccine deal

Yahoo07-05-2025

The European Union has snapped up advanced manufacturing capacity for at least 478 million doses of pandemic flu vaccine, surging ahead in the race to prepare for a possible bird flu outbreak in humans.
According to data from the health analytics firm Airfinity, the EU now has signed agreements with seven manufacturers to reserve vaccines – including a new deal unveiled last week with CSL Seqirus for a further 27m doses.
Although governments including Canada and the UK have reserved more doses per person, the EU has the largest and most diverse supply chain for a possible influenza pandemic.
As reported in the Lancet last week, the recent emergence of highly pathogenic H5N1 avian influenza virus infections in dairy cows and humans in the US has 'raised alarms regarding the potential for a pandemic'.
'Over 995 dairy cow herds and at least 70 humans have been affected, including cases of severe disease and the first reported H5N1-related death in the U.S'.
This emerging threat has caused health authorities across the globe to quietly start planning for a possible spillover to humans, with a clear focus on vaccine supply.
The shots the EU now has on standby do not constitute a stockpile. Rather than amassing a store of ready-to-use vaccines which protect against known strains of bird flu, the bloc has bet big on reserving access to outbreak-specific shots.
These would be produced after a pandemic was declared and the exact strain of the virus was known – giving the best chance of the jabs being efficacious in humans.
Richard Bennett, lead analyst at Airfinity, said the EU was also hedging its bets by doing deals with seven different firms.
'This diversification reduces the risk of supply disruption if one manufacturer encounters production issues, and prevents monopolising capacity from any single supplier,' he said.
Other countries have also set about reserving access to as-yet-unmade vaccines. Germany has secured production capacity or 400 million doses, under a framework that would also distribute manufactured jabs to the wider European Union.
Vaccine resilience and flexibility
Meanwhile the UK and Canada have reserved 100m and 80m doses respectively. Although this equates to more shots per person than the EU has access to (1.5 per capita for Britain, two for Canada and one for the EU), the supply chains are less diverse. Canada is reliant on GSK, while the UK has a single deal with CSL Seqirus, according to Airfinity.
Unlike the other countries included in the analysis, the US does not have enough doses to cover its entire population. Mr Bennet said this is unsurprising, 'given previous [US] demand for pandemic vaccines'.
During the H1N1 'swine flu' outbreak in 2009, national vaccine coverage was just 27 per cent, though this jumped to 69.5 per cent during the coronavirus pandemic.
Still, the superpower has 250m doses of pandemic flu shots reserved with CSL Seqirus and Sanofi, plus a stockpile of 20m shots against known strains of bird flu already circulating.
'Most countries depend on a handful of manufacturers for pandemic flu vaccines. Seven companies produce over 85 per of global supply, leaving national stockpiles vulnerable to geopolitical tensions, production delays, or supply chain shocks,' the Airfinity analysis warned.
'The EU has reduced reliance on single suppliers by securing contracts with multiple manufacturers, creating a more resilient and flexible vaccine procurement strategy during emergencies.'
Production delays and vaccine nationalism
The coronavirus pandemic highlighted the threat of vaccine nationalism, production delays and export restrictions. India's export bans, for instance, stalled the rollout of shots from Covax, which sought to buy immunisations for developing countries.
The US also imposed limits on the export of vaccines and the critical equipment and materials needed to make them, while the EU threatened to block the export of AstraZeneca shots made for the UK government in the Netherlands.
Ray Longstaff, director for Pandemic and Outbreak Preparedness and Response at CSL Seqirus, said the company has designed its manufacturing network and contracts to ensure minimum disruption in the face of these sorts of threats.
'In our agreements, we have supplied safeguards and comprehensive information about how we will not only meet the timelines … but also the kind of preparedness measures that we put in place to protect supply chains,' he said. 'It's something that we take very seriously.'
CSL Seqirus Liverpool's refrigerated warehouse, where vaccines for flu – including H5N1 – are stored before shipment - Simon Townsley/The Telegraph
The company – which has manufacturing sites in the UK, US and Australia – is one of the world's largest producers of seasonal flu shots. It also has a bird flu vaccine programme, plus a separate initiative to create pandemic-specific vaccines. If the WHO declared a pandemic, all manufacturing would switch to solely respond to the given outbreak.
The pharmaceutical firm's latest deal reserves 27.5m pandemic flu doses for 17 participating EU member states, which would be manufactured at the CSL Seqirus site in Liverpool using an egg-based production method. The company now has deals to supply pandemic shots to more than 30 governments worldwide, including the UK.
Mr Longstaff said he could not discuss specifics of the contracts – which include reservation fees that are invested in 'maintaining readiness and preparedness' – and downplayed the ramifications of potential tensions between governments in a pandemic scenario.
He also stressed that the company would support lower income countries through the WHO's Pandemic Influenza Preparedness (PIP) framework. Agreed after the 2009 swine flu outbreak, this requires companies to donate 10 per cent of their pandemic influenza shots, in real time.
This principle has also been incorporated into the new WHO pandemic treaty, set to be approved at the World Health Assembly in Geneva later this month, in an attempt to ensure that wealthy countries are not the only ones who have access to medical countermeasures in the event of an outbreak.
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What The June 28 European Accessibility Act Deadline Means For Brands
What The June 28 European Accessibility Act Deadline Means For Brands

Forbes

timean hour ago

  • Forbes

What The June 28 European Accessibility Act Deadline Means For Brands

This photograph taken on March 19, 2025 shows European flags outside the EU headquarters in ... More Brussels. (Photo by Nicolas TUCAT / AFP) (Photo by NICOLAS TUCAT/AFP via Getty Images) In less than a week from now, on June 28, 2025, the requirements of the European Accessibility Act come into force. The intention behind the EAA is to provide fair and equitable access to digital products to the more than 100 million consumers with disabilities living across the European Union. One of the key things to keep in mind about the EEA is that it doesn't just affect European companies. It applies to any organization from around the world selling into the EU market. It goes beyond standard web accessibility and e-commerce, incorporating areas such as computers and operating systems, smartphones, digital TV services, ATMS, ticketing machines and other digital kiosks within its remit. The legislation requires companies to do more than simply make digital products and content accessible. Instead, it seeks to embed accessibility commitments and best practices at a more fundamental organizational level through requirements like official accessibility statements and providing specialized training to staff. Non-compliance with the EAA can lead to fines and ultimately the termination of EU market access. The proximity of the deadline may for some be a cause for panic but cutting through the noise, here are what some digital accessibility specialists are urging organizations to keep in mind with less than a week to go: It's still not too late to get started 'It's not too late to start addressing accessibility. Starting now is better than not doing anything about EAA compliance,' says Jon Avila, Chief Accessibility Officer at Level Access, one of the leading providers of digital accessibility services in the United States. Avila continues, 'For organizations just getting started, the most important steps to take now to mitigate risk are demonstrating that you're taking action to make sustained progress, and beginning to put processes in place aligned with EAA requirements. One of the biggest gaps we observe is third-party content. Companies often assume that embedded tools or plugins are outside their responsibility, but under the EAA, they're very much in scope. We recommend that organizations make accessibility a requirement during the procurement process and request documented proof of accessibility (e.g., a completed VPAT report) from vendors prior to making a purchase.' Eric Portis, a Developer Evangelist at Cloudinary, a software company that helps organizations manage their visual content online, also agrees that it's still not too late to get started with EAA compliance. 'The best time to consider the accessibility of a project was before you shipped it, but the second-best time is today. The Web Content Accessibility Guidelines are just a big checklist. And while checking every item off the list before June is not a realistic goal for many teams, everyone can start tackling an item or two and begin building momentum towards full compliance. All progress is good progress,' Portis says. The AI landscape has changed Back in 2020, when AI website accessibility overlay widgets hit the market, they were met with a degree of skepticism. That's because the marketing claims were bold – buy a software subscription and let AI do its magic in both spotting and fixing accessibility fails, saving you time and money. It quickly became widely accepted that the technology was, in fact, nowhere near ready to entirely replace human oversight for accessibility remediation. Fast forward five years, and the same remains true but the technology has undoubtedly gotten a lot better meaning that, though AI won't solve all digital accessibility issues, it can now do a lot more of the heavy lifting which genuinely allows teams to focus more precisely on the more nuanced human elements related to user experience. What this ultimately means for the market was recently brought into sharp relief in a report authored by AAAnow, leading digital compliance benchmarking specialists based in London. AAAnow's report looked at the websites of organizations comprising The Valuable 500, a collective of some of the most profitable companies on the planet with long-standing pledges to accessibility and inclusion, including the likes of Apple, Google and BP. According to the V500 scorecard, the average member organization manages around 178 websites, each comprising around 211 pages. To remediate accessibility on the average of 85% of pages where it is required would take 3,480 workdays, or 13 full-time staff working for a year (per org). In terms of cost, this equates to $767,000 per company just for initial compliance, let alone maintenance. Scaled across the full Valuable 500, that's over $380 million and 9 years of full-time work at current capacity. 'We argue that only a risk-managed, AI-powered approach can address the scale, cost, and operational complexity. It's not a 'nice-to-have' - it's fundamental,' commented AAAnow CEO Lawrence Shaw in an earlier interview. Regulation is not something to fear Instinctively, when any type of new regulation comes into force, particularly one that potentially involves fines and other punitive measures, fear and trepidation tend to be the most common reactions off the bat. Yet, it can be argued that brands should welcome the new regulations from the EU as they provide clarity and a roadmap into areas of technical compliance that have previously been murky. In a recent company press release, Amit Borsok, CEO of Italy-based Accessiway, which takes an end-to-end approach to accessibility remediation involving both automation and human testers, said, 'European regulations have shifted the narrative around accessibility from a compliance issue to a strategic investment. Until now, regulatory fragmentation across member states has prevented companies from fully capitalizing on this potential, increasing compliance costs and limiting competitiveness. 'Now, instead of being a hurdle, the new framework provides clarity that encourages companies to invest in accessible technologies and services to expand their market reach. For many organizations, accessibility has evolved from a nice-to-have to a competitive necessity. With regulation now offering predictability and standardization, uncertainty is reduced for investors, and new opportunities for innovation are unlocked.' Though the word deadline usually implies finality, whether, as an organization, you are right at the start of your digital accessibility journey and anxiously playing catch-up, or significantly further down the line, June 28 will surely be the opening of a new chapter for all involved. The story about to unfold will be one of whether human intention layered onto ever more advanced technology can ultimately help make access to the digital realm an equitable experience for everyone.

Some Johns Hopkins, UMD research stopped after Trump cuts. Others are scrambling to resume
Some Johns Hopkins, UMD research stopped after Trump cuts. Others are scrambling to resume

Miami Herald

time4 hours ago

  • Miami Herald

Some Johns Hopkins, UMD research stopped after Trump cuts. Others are scrambling to resume

BALTIMORE - Some Maryland university research projects on the Trump administration's chopping block have been fully discontinued, while others are scrambling to resume after a pause in funding. Johns Hopkins has lost more than $800 million in federal grant money. The University of Maryland lost tens of millions of dollars. But some cuts have been blocked by legal challenges, though litigation is ongoing. Researchers describe disappointment and uncertainty as they determine how to move forward. Alternative funding has been secured for a clinical trial in Bangladesh aimed at managing life-threatening diarrheal diseases in children, which was previously halted because of U.S. Agency for International Development funding cuts. The work has yet to resume. "It just takes a long time to rebuild the teams and get things in place again to start," said Judd Walson, chair of the Department of International Health at Johns Hopkins University, which partnered on the project. "The disruptions that are happening are really catastrophic." Over the past several weeks, 17 NIH awards have been terminated or had an unclear status, including two training awards supporting doctoral-level researchers, Walson said. "We're not getting a lot of communication, so it's a little bit hard to say exactly what the status of some of these awards are," he said. The National Institutes of Health didn't respond to questions about funding cuts to Maryland research institutions. In a lawsuit challenging NIH research cuts, lawyers for the federal government wrote in a recent court filing that its terminations of grants for DEI-related studies were "sufficiently reasoned," and that the NIH has "broad discretion" to decide what grants to provide. Johns Hopkins is a plaintiff in two lawsuits involving caps on reimbursement of indirect costs for research - one challenging the NIH and the other against the Department of Defense. The latter suit also lists the University of Maryland, College Park, as a plaintiff. Both schools have also filed a brief in support of a lawsuit filed by Harvard University against the Trump administration's funding cuts. New grant terminations have been arriving "nearly every week," Johns Hopkins University said in a recent update published on its website. There's also been a nearly two-thirds decrease in new awards compared with last year, the university said. Johns Hopkins atmosphere and ocean sciences researcher Darryn Waugh was disappointed upon receiving notice that his NASA grant to study air pollution in Baltimore was canceled by the Trump administration. The termination came as a result of President Donald Trump's executive order, "Ending Radical and Wasteful Government DEI Programs and Preferencing." "It wasn't clear to me that this actually falls under this diversity, equity, inclusion," Waugh said. "It was research that I think we still wanted to do - to understand how the air pollution varies through the city - and the environmental justice was only actually a relatively small component of it." Waugh was working through the second year of a three-year grant, totaling $1,465,950. "We've got kind of a preliminary analysis," he said, regarding the research. "But to get anything conclusive, we would need more than one year of funding." Waugh said he intends to find ways of continuing the research without the NASA grant. Daniel Mullins, at the University of Maryland School of Pharmacy, had a grant canceled for a "Health Equity Research Hub," which examined how to encourage greater participation in health-related research. Mullins said the loss of the grant affected five positions, and the individuals will be removed from the university because of lack of funding. He added that the termination stated that the grant was DEI-related, which he disputes. "I think under the DEI umbrella, a lot of times, the government will refer to it as just one racial ethnic group," he said. "We've worked in different geographies, in different racial and ethnic populations, but what's cool about what we do is it really does apply to all patients in all populations." Mullins said his research group has additional funding from other agencies and is writing new proposals. Walson said social determinants of health - involving factors like poverty and other "inequities" - are "foundational to our understanding of health." "So the idea that we would not be able to pursue work that focuses on identifying and managing those particular issues, which are the underlying, core issues at the heart of health issues, is really challenging," Walson said. The Trump administration's cuts have had an ieffect across the world. Walson said it's estimated the cuts will result in hundreds of thousands of deaths globally, and could eventually lead to millions of deaths over the next couple of years. Secretary of State Marco Rubio has said it's "a lie" that people have died because of USAID cuts. During a congressional hearing in May, Rubio said the U.S. is the world's "largest humanitarian provider." "I would argue: How many people die because China hasn't done it?" he said. "How many people have died because the U.K. has cut back on spending and so has other countries?" Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.

What Trump's Strikes on Iran Mean for Gas Prices As Oil Costs Surge
What Trump's Strikes on Iran Mean for Gas Prices As Oil Costs Surge

Miami Herald

time4 hours ago

  • Miami Herald

What Trump's Strikes on Iran Mean for Gas Prices As Oil Costs Surge

Amid the conflict between Israel and Iran, oil prices have been surging, and after President Donald Trump announced on Saturday the U.S. would be joining the attack on Iran's nuclear sites, concern has been raised over what this means for gas prices in America. The U.S. dropped bombs on Iran's three main nuclear sites on Saturday night—Fordow, Natanz and Isfahan—escalating fears of an expansion of the Middle Eastern conflict that could throw the oil market into turmoil. With much of the West already seeing spikes in costs, further increases could be looming as the conflict continues. After the U.S. attack, the Iran's reaction will reveal whether the conflict could develop into a major regional or even international conflict. Iran may retaliate against U.S. forces in the region, cut off a global oil supply route or try to accelerate its nuclear program. Although, Trump has warned of further military action if Tehran does not now decide to make peace. In the past week, Brent Crude oil stocks have already jumped 11 percent since Israel attacked Iran and is expected to continue rising on Monday, according to Emirati newspaper Gulf News, although prices have been fluctuating. The oil market had stabilized on Friday, according to Reuters, after the U.S. imposed new Iran-related sanctions, which fueled hopes that a negotiated agreement could be made between the two countries. That relief in the market was only temporary as after Iran threatened to close the Strait of Hormuz, the world's most important oil chokepoint, in response to the U.S. strikes. Fears that Iran could attack U.S. oil infrastructure in the region, and levy its power over the Straits of Hormuz could "combine to make prices and speculation rise about the security and dependability of supply," Greg Kennedy, director of the Economic Conflict and Competition Research Group at King's College London told Newsweek. "Lack of clarity of how long this condition will last will also lead to hoarding or preemptive purchasing by other nations, so there are competition supply fears that will drive up prices," he added. Reflecting on the knock-on effect this would have on U.S. gas prices, Kennedy said that in the long term, the conflict "will most certainly see energy prices go up at the pumps." "This is not an act that just stays in the Gulf region, it has wider global strategic ripples," he said. Kennedy said that higher oil prices could also mean that Russia is able to gain more money—oil from the Urals region has already increased by 26 percent in the past month. "This is making war in Ukraine last longer now as well as it gives [President Vladimir] Putin both political and economic ammunition to continue his war efforts and avoid the need for peace talks." Greg Kennedy, director of the Economic Conflict and Competition Research Group at King's College London told Newsweek: "The overall impact of actions that make the world look even less safe than it was previously was is always a cost to the civilian sector and society as a whole." As the conflict, and its repercussions, continue to unfold in the next few days, it will become more clear how significant the prices hikes will be. Related Articles Donald Trump Warns Iran Against 'Any Retaliation' After US Strikes: Live UpdatesExclusive: Hezbollah Says It Won't Join Fight After US Attacks IranTrump Warns Iran To Make Peace or Face Further StrikesAOC Says Trump's Iran Strikes 'Clearly Grounds for Impeachment' 2025 NEWSWEEK DIGITAL LLC.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store